DYNAMIC SURVIVAL MODELS FOR
PREDICTING THE FUTURE IN HEALTH
TECHNOLOGY ASSESSMENT
Dynamic survival models for predicting the future in health technology assessment and incorporating external evidence
Dynamic survival models for predicting the future in health technology assessment and incorporating external evidence
Dynamic survival models for predicting the future in health technology assessment and incorporating external evidence
TIME SERIES METHODS
Example survival data
• Varying sample size
• Unequal observations
• Censoring
Dynamic survival models for predicting the future in health technology assessment and incorporating external evidence
Dynamic survival models
Number of deaths at time 𝑡𝑖 = 𝑌𝑡 𝑖
𝑌𝑡 𝑖
~ Poisson(exp 𝛽1,𝑡 𝑖
× 𝜏 𝑡 𝑖
)
𝛽1,𝑡 𝑖
= 𝛽1,𝑡 𝑖−1
+ 𝛽2,𝑡 𝑖−1
𝛽2,𝑡 𝑖
~ Normal(𝛽2,𝑡 𝑖−1
, 𝑍)
Extrapolations at time ℎ after follow-up (𝑡𝑖 = 𝑇):
ො𝑦 𝑇+ℎ = exp 𝛽1,𝑇 + ℎ ∗ 𝛽2,𝑇
Extrapolation performance with a
cured fraction: a simulation study.
Curative treatments
Survival data simulated from
a Weibull cure model.
Cure fraction = 25%
Mean survival:
• Cured ≈ 20 years
• Uncured ≈ 2 years
Each dataset had 100 people
with follow-up = 4 years.
200 datasets were simulated.
Dynamic survival models
with a cured fraction
Extrapolation models
1. Weibull cure model (correctly specified)
2. Lognormal cure model (misspecified)
3. Royston Parmar cure model (over-specified)
4. Dynamic survival cure model (over-specified)
Simulation study
Simulation study
Simulation study
Simulation study
Simulation study
Simulation study
Simulation study
Shorter follow-up (Two years)
Models without a cure fraction (Follow-up = 4 years, n = 100)
Dynamic survival models in HTA:
a case-study
Company ICER: £86,000
Evidence review group (ERG):
company extrapolations “wholly
implausible”. ICER: £133,000
Impacts on £ discount required
Dynamic survival models + general population mortality =
Dynamic relative survival models
General population mortality = 𝜆 𝑡 𝑖
𝑃
𝑌𝑡 𝑖
~ Poisson( exp 𝛽1,𝑡 𝑖
+ 𝜆 𝑡 𝑖
𝑃
× 𝜏 𝑡 𝑖
)
exp 𝛽1,𝑡 𝑖
= disease-specific (excess) hazard.
Dynamic survival models + general population mortality =
Dynamic relative survival models
Use different time series models for different
assumptions about extrapolated excess hazard:
• Decrease to zero = local trend model
• Constant = local level model
• Short-term decrease, long-term constant =
damped trend model.
Within-sample estimates and extrapolations
Impact on cost-effectiveness
Model ICER
Company (log-logistic) £86,000
Excess risk ↘ 0 £122,000
ERG (hybrid) £133,000
Constant excess risk £140,000
Excess risk ↘ constant £143,000
Sensitivity of the ERG ICER to cut-point
Dynamic survival models for predicting the future in health technology assessment and incorporating external evidence
Winning method:
1. Dynamic model
2. Model averaging
3. Incorporate external
data (via long short-
term memory recurrent
neural network)
Conclusions
“Survival data is inherently time series data”
(https://www.jstor.org/stable/2348523)
Thank you for listening!
Any questions?
Acknowledgements: I would like to thank my supervisors. I am funded by
the National Institute for Health Research (DRF-2016-09-119). This research was
supported by the NIHR CLAHRC Yorkshire and Humber (NIHR CLAHRC YH).
www.clahrc-yh.nihr.ac.uk. The views expressed are those of the author, and not
necessarily those of the NIHR or the Department of Health and Social Care.

More Related Content

PPTX
Survival Analysis With Generalized Additive Models
PPTX
Survival analysis
PPTX
Presentation of Project.pptx
PDF
Survival analysis & Kaplan Meire
PDF
Research on Haberman dataset also business required document
PDF
Big Data Analytics for Healthcare
PDF
Extrapolation of time-to-event data
DOC
Non-Parametric Survival Models
Survival Analysis With Generalized Additive Models
Survival analysis
Presentation of Project.pptx
Survival analysis & Kaplan Meire
Research on Haberman dataset also business required document
Big Data Analytics for Healthcare
Extrapolation of time-to-event data
Non-Parametric Survival Models

Similar to Dynamic survival models for predicting the future in health technology assessment and incorporating external evidence (20)

PDF
Logistic Loglogistic With Long Term Survivors For Split Population Model
PDF
Use Proportional Hazards Regression Method To Analyze The Survival of Patient...
PPTX
6 Natural History of Disease.pptx for the
PPTX
Estimating survival data from published Kaplan-Meier curves: A comparison of ...
PPTX
Economic evaluation of changes to the organisation and delivery of health ser...
PDF
An illustration of the usefulness of the multi-state model survival analysis ...
PDF
Survival analysis & Kaplan Meire
PPT
Part 2 Cox Regression
PDF
Survival Analysis Models And Applications Xian Liuauth
PPT
Parametric Survival Analysis in Health Economics
PPT
Part 1 Survival Analysis
PDF
Determination of Hazard State of Non-Communicable Diseases Using Semi-Markov...
PPTX
Survival analysis
PDF
Personalized Screening using Joint Models
PDF
A gentle introduction to survival analysis
PDF
EDA On Haberman Data
PDF
Projecting ‘time to event’ outcomes in technology assessment: an alternative ...
PPTX
Contemporary Approaches to Survival Data Analysis by Dr. Idokoko A. B.
PDF
Common statistical pitfalls & errors in biomedical research (a top-5 list)
PPTX
Survival Data Analysis for Sekolah Tinggi Ilmu Statistik Jakarta
Logistic Loglogistic With Long Term Survivors For Split Population Model
Use Proportional Hazards Regression Method To Analyze The Survival of Patient...
6 Natural History of Disease.pptx for the
Estimating survival data from published Kaplan-Meier curves: A comparison of ...
Economic evaluation of changes to the organisation and delivery of health ser...
An illustration of the usefulness of the multi-state model survival analysis ...
Survival analysis & Kaplan Meire
Part 2 Cox Regression
Survival Analysis Models And Applications Xian Liuauth
Parametric Survival Analysis in Health Economics
Part 1 Survival Analysis
Determination of Hazard State of Non-Communicable Diseases Using Semi-Markov...
Survival analysis
Personalized Screening using Joint Models
A gentle introduction to survival analysis
EDA On Haberman Data
Projecting ‘time to event’ outcomes in technology assessment: an alternative ...
Contemporary Approaches to Survival Data Analysis by Dr. Idokoko A. B.
Common statistical pitfalls & errors in biomedical research (a top-5 list)
Survival Data Analysis for Sekolah Tinggi Ilmu Statistik Jakarta
Ad

More from cheweb1 (20)

PDF
The value of Value of Information (VoI): When and how to use simpler or heuri...
PDF
Withinfamily che presentation_200609
PDF
Healthy Minds: A Randomised Controlled Trial to Evaluate PHSE Curriculum Deve...
PDF
Valuation in health economics: Reflections of a UK health economist… and patient
PDF
Health Research Authority Approval: Information for Sponsors
PDF
Modeling the cost effectiveness of two big league pay-for-performance policies
PDF
Baker what to do when people disagree che york seminar jan 2019 v2
PDF
The longest-lasting, most popular, and yet most thoroughly discredited idea i...
PDF
Cost-effectiveness of diagnosis: tests, pay-offs and uncertainties
PDF
Insights from actuarial science into HTA: Building joint models of random qua...
PDF
The implications of parameter independence in probabilistic sensitivity analy...
PDF
Adjusting for treatment switching in randomised controlled trials
PDF
Discounting future healthcare costs and benefits (part 2)
PDF
Discounting future healthcare costs and benefits(Part 1)
PDF
The reference ICER for the Australian health system: estimation and barriers ...
PPTX
Valuing paediatric preference-based measures: using a discrete choice experim...
PDF
Does transfer to intensive care units reduce mortality for deteriorating ward...
PDF
Quantifying the added societal value of public health interventions in reduci...
PDF
Population-adjusted treatment comparisons: estimates based on MAIC (Matching-...
PDF
The economics of providing health care in prisons – a fiscal fugitive
The value of Value of Information (VoI): When and how to use simpler or heuri...
Withinfamily che presentation_200609
Healthy Minds: A Randomised Controlled Trial to Evaluate PHSE Curriculum Deve...
Valuation in health economics: Reflections of a UK health economist… and patient
Health Research Authority Approval: Information for Sponsors
Modeling the cost effectiveness of two big league pay-for-performance policies
Baker what to do when people disagree che york seminar jan 2019 v2
The longest-lasting, most popular, and yet most thoroughly discredited idea i...
Cost-effectiveness of diagnosis: tests, pay-offs and uncertainties
Insights from actuarial science into HTA: Building joint models of random qua...
The implications of parameter independence in probabilistic sensitivity analy...
Adjusting for treatment switching in randomised controlled trials
Discounting future healthcare costs and benefits (part 2)
Discounting future healthcare costs and benefits(Part 1)
The reference ICER for the Australian health system: estimation and barriers ...
Valuing paediatric preference-based measures: using a discrete choice experim...
Does transfer to intensive care units reduce mortality for deteriorating ward...
Quantifying the added societal value of public health interventions in reduci...
Population-adjusted treatment comparisons: estimates based on MAIC (Matching-...
The economics of providing health care in prisons – a fiscal fugitive
Ad

Recently uploaded (20)

PPTX
Impression Materials in dental materials.pptx
PPTX
@K. CLINICAL TRIAL(NEW DRUG DISCOVERY)- KIRTI BHALALA.pptx
PPTX
Vesico ureteric reflux.. Introduction and clinical management
PDF
MNEMONICS MNEMONICS MNEMONICS MNEMONICS s
PDF
Forensic Psychology and Its Impact on the Legal System.pdf
PPT
nephrology MRCP - Member of Royal College of Physicians ppt
PPTX
abgs and brain death dr js chinganga.pptx
PPT
Dermatology for member of royalcollege.ppt
PDF
Glaucoma Definition, Introduction, Etiology, Epidemiology, Clinical Presentat...
PPTX
Hypertensive disorders in pregnancy.pptx
PDF
OSCE SERIES - Set 7 ( Questions & Answers ).pdf
PDF
The_EHRA_Book_of_Interventional Electrophysiology.pdf
PPTX
Physiology of Thyroid Hormones.pptx
PDF
The Digestive System Science Educational Presentation in Dark Orange, Blue, a...
PPTX
CARDIOVASCULAR AND RENAL DRUGS.pptx for health study
PPTX
Reading between the Rings: Imaging in Brain Infections
PDF
04 dr. Rahajeng - dr.rahajeng-KOGI XIX 2025-ed1.pdf
PPT
Rheumatology Member of Royal College of Physicians.ppt
PDF
OSCE SERIES ( Questions & Answers ) - Set 3.pdf
PPTX
Critical Issues in Periodontal Research- An overview
Impression Materials in dental materials.pptx
@K. CLINICAL TRIAL(NEW DRUG DISCOVERY)- KIRTI BHALALA.pptx
Vesico ureteric reflux.. Introduction and clinical management
MNEMONICS MNEMONICS MNEMONICS MNEMONICS s
Forensic Psychology and Its Impact on the Legal System.pdf
nephrology MRCP - Member of Royal College of Physicians ppt
abgs and brain death dr js chinganga.pptx
Dermatology for member of royalcollege.ppt
Glaucoma Definition, Introduction, Etiology, Epidemiology, Clinical Presentat...
Hypertensive disorders in pregnancy.pptx
OSCE SERIES - Set 7 ( Questions & Answers ).pdf
The_EHRA_Book_of_Interventional Electrophysiology.pdf
Physiology of Thyroid Hormones.pptx
The Digestive System Science Educational Presentation in Dark Orange, Blue, a...
CARDIOVASCULAR AND RENAL DRUGS.pptx for health study
Reading between the Rings: Imaging in Brain Infections
04 dr. Rahajeng - dr.rahajeng-KOGI XIX 2025-ed1.pdf
Rheumatology Member of Royal College of Physicians.ppt
OSCE SERIES ( Questions & Answers ) - Set 3.pdf
Critical Issues in Periodontal Research- An overview

Dynamic survival models for predicting the future in health technology assessment and incorporating external evidence